BRPI0809958B8 - conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico - Google Patents

conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico

Info

Publication number
BRPI0809958B8
BRPI0809958B8 BRPI0809958A BRPI0809958A BRPI0809958B8 BR PI0809958 B8 BRPI0809958 B8 BR PI0809958B8 BR PI0809958 A BRPI0809958 A BR PI0809958A BR PI0809958 A BRPI0809958 A BR PI0809958A BR PI0809958 B8 BRPI0809958 B8 BR PI0809958B8
Authority
BR
Brazil
Prior art keywords
hpv
spheres
strains
detecting
differentiating
Prior art date
Application number
BRPI0809958A
Other languages
English (en)
Inventor
Daniel J Park
Karl F Poetter
Zaheer Khan
Original Assignee
Genera Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genera Biosystems Ltd filed Critical Genera Biosystems Ltd
Publication of BRPI0809958A2 publication Critical patent/BRPI0809958A2/pt
Publication of BRPI0809958B1 publication Critical patent/BRPI0809958B1/pt
Publication of BRPI0809958B8 publication Critical patent/BRPI0809958B8/pt
Publication of BRPI0809958C1 publication Critical patent/BRPI0809958C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

composições e métodos de detecção. a presente invenção relaciona-se de forma geral ao campo de ensaios diagnósticos e de detecção. mais particularmente, a presente invenção fornece métodos e reagentes que incluem biochips para a detecção da presença de, ou distinção entre, um ou mais analitos em uma amostra. figura 5
BRPI0809958A 2007-04-05 2008-04-04 conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico BRPI0809958C1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US91037307P 2007-04-05 2007-04-05
US91038107P 2007-04-05 2007-04-05
US60/910,381 2007-04-05
US60/910,373 2007-04-05
PCT/US2008/004441 WO2008124091A2 (en) 2007-04-05 2008-04-04 Compositions and methods of detection

Publications (4)

Publication Number Publication Date
BRPI0809958A2 BRPI0809958A2 (pt) 2008-10-16
BRPI0809958B1 BRPI0809958B1 (pt) 2020-12-01
BRPI0809958B8 true BRPI0809958B8 (pt) 2021-06-15
BRPI0809958C1 BRPI0809958C1 (pt) 2021-07-27

Family

ID=39831523

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0809958A BRPI0809958C1 (pt) 2007-04-05 2008-04-04 conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico

Country Status (11)

Country Link
US (2) US8278429B2 (pt)
EP (1) EP2142926B1 (pt)
JP (1) JP2010523114A (pt)
CN (1) CN101730847B (pt)
AU (1) AU2008236678B2 (pt)
BR (1) BRPI0809958C1 (pt)
ES (1) ES2403729T3 (pt)
MX (1) MX2009010751A (pt)
NZ (1) NZ580242A (pt)
RU (1) RU2480732C2 (pt)
WO (1) WO2008124091A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100227315A1 (en) 2004-05-26 2010-09-09 Paul Mulvaney Biosensor Using Whispering Gallery Modes in Microspheres
RU2480732C2 (ru) * 2007-04-05 2013-04-27 Дженера Байосистемз Лимитед Композиции и способы выявления
US10679749B2 (en) 2008-08-22 2020-06-09 International Business Machines Corporation System and method for virtual world biometric analytics through the use of a multimodal biometric analytic wallet
NZ601652A (en) * 2010-01-19 2014-10-31 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Set of probes for the detection and typing of 46 human papillomavirus mucosal types
US8263388B2 (en) * 2010-06-10 2012-09-11 The Hong Kong Polytechnic University Method and apparatus for detecting specific DNA sequences
EP2764125B1 (en) * 2011-10-04 2018-02-21 Genera Biosystems Limited Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads
WO2013098821A1 (en) * 2011-12-29 2013-07-04 Parasight Ltd. Methods and systems for detecting a pathogen in a biological sample
AT521238B1 (de) 2018-05-09 2020-02-15 Lifetaq Analytics Gmbh In-situ zellanalyse im zellkultursystem
RU2734957C1 (ru) * 2020-04-20 2020-10-26 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук Биомедицинский материал для диагностики патологий в биологических тканях
RU2766938C1 (ru) * 2021-06-30 2022-03-16 Александр Федорович Попов Способ выполнения космохимического исследования

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876922A (en) * 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
US5411857A (en) * 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
CA1276575C (fr) * 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
DE3779175D1 (de) * 1986-03-21 1992-06-25 Pasteur Institut Bestimmte, von einem papillomavirus-genom abgeleitete dns-sequenzen, deren anwendungen fuer in vitro-diagnostische zwecke und die herstellung von antigenzusammensetzungen.
AU619170B2 (en) * 1987-01-09 1992-01-23 Abbott Laboratories Diagnostic assays using nucleic acid probes
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
CA1339729C (en) * 1988-10-26 1998-03-17 Wayne D. Lancaster Human papillomavirus type 52 dna sequences and methods for employing thesame
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
NL9000134A (nl) * 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US5484699A (en) * 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
FR2670797A1 (fr) * 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
ES2193133T3 (es) * 1991-07-13 2003-11-01 Dade Behring Marburg Gmbh Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
US5346811A (en) * 1991-07-22 1994-09-13 Cerveceria Polar Method and products for human papillomavirus detection
JP3659646B2 (ja) * 1994-02-21 2005-06-15 スティヒティング リサーチフォンズ パトロジー 普遍プライマーを用いる核酸増幅方法によるヒト乳頭腫ウィルス検出
CA2163393C (en) * 1994-11-30 2003-04-22 Colleen Marie Nycz Amplification and detection of mycobacteria nucleic acids
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
WO1997018334A2 (en) * 1995-11-15 1997-05-22 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
US6511805B1 (en) * 1996-03-15 2003-01-28 The Penn State Research Foundation Methods for detecting papillomavirus DNA in blood plasma and serum
US6265154B1 (en) * 1996-10-25 2001-07-24 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
DE69806024T2 (de) * 1997-09-16 2003-02-13 Delft Diagnostic Laboratory B.V., Delft Erkennung und identifizierung von menschlichem papillomavirus durch pcr und typ-spezifischer reverser hybridisierung
ZA989950B (en) * 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
JP2003505034A (ja) * 1999-07-19 2003-02-12 ケンブリッジ・ユニバーシティ・テクニカル・サービシーズ・リミテッド 存在量の少ない核酸配列を増幅する方法および該方法を行うための手段
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US20020081617A1 (en) * 2000-11-08 2002-06-27 Tione Buranda Fluorescence and FRET based assays for biomolecules on beads
JP2005500856A (ja) 2001-08-23 2005-01-13 メルク　エンド　カムパニー　インコーポレーテッド 多重フルオロフォアを使用する蛍光多重ｈｐｖｐｃｒアッセイ
US20030224385A1 (en) * 2001-12-07 2003-12-04 German Pihan Targeted genetic risk-stratification using microarrays
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
US7901883B2 (en) * 2004-12-10 2011-03-08 Genera Biosystems Limited Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
CN101341257B (zh) * 2004-12-10 2012-10-10 杰纳罗生物系统有限责任公司 使用核酸探针、微珠和荧光激活的细胞分选器(facs)检测人乳头状瘤病毒(hpv)
JP2008524990A (ja) * 2004-12-23 2008-07-17 ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド ヒトパピローマウイルスの検出
GB0500996D0 (en) * 2005-01-18 2005-02-23 Delfts Diagnostic Labaratory B Detection method and materials therefor
RU2480732C2 (ru) * 2007-04-05 2013-04-27 Дженера Байосистемз Лимитед Композиции и способы выявления

Also Published As

Publication number Publication date
WO2008124091A2 (en) 2008-10-16
JP2010523114A (ja) 2010-07-15
HK1140019A1 (en) 2010-09-30
AU2008236678B2 (en) 2013-09-12
BRPI0809958B1 (pt) 2020-12-01
US20130184170A1 (en) 2013-07-18
RU2480732C2 (ru) 2013-04-27
US20100279888A1 (en) 2010-11-04
NZ580242A (en) 2012-02-24
CN101730847A (zh) 2010-06-09
AU2008236678A1 (en) 2008-10-16
BRPI0809958A2 (pt) 2008-10-16
MX2009010751A (es) 2010-03-08
CN101730847B (zh) 2015-03-18
BRPI0809958C1 (pt) 2021-07-27
WO2008124091A3 (en) 2009-01-15
EP2142926A4 (en) 2010-08-04
EP2142926A2 (en) 2010-01-13
ES2403729T3 (es) 2013-05-21
RU2009140736A (ru) 2011-05-10
EP2142926B1 (en) 2012-12-05
US8278429B2 (en) 2012-10-02

Similar Documents

Publication Publication Date Title
BRPI0809958C1 (pt) conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico
Jo et al. Diverse human skin fungal communities in children converge in adulthood
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
BRPI0906858B8 (pt) métodos in vitro para detectar a presença de uma célula de câncer em um indivíduo e para identificar uma assinatura específica de tumor em um indivíduo tendo câncer.
PH12018550037A1 (en) Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof
BR112014010718A2 (pt) métodos e sistemas para detecção de analito em amostra
WO2011142836A3 (en) Assays for the detection of genotype, mutations, and/or aneuploidy
BRPI0909620A2 (pt) "dispositivo microfluídico para detectar a presença de um ou mais análitos em uma amostra de saliva, método para detectar a presença de um ou mais análitos em uma amostra de saliva e método para detectar em um dispositivo microfluídico um análito e uma amostra de saliva que copreende a mucina"
BR112013026502A2 (pt) "métodos para detecção localizada de ácido nucleico em amostra de tecido, bem como matriz para uso na referida detecção de ácido nucleico e seu método de preparação ou produção".
ATE533061T1 (de) Verfahren zur diagnose bakterieller infektionen
BR112012032537A2 (pt) biomarcadores de câncer de pulmão e suas utilizações
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BRPI0812771A2 (pt) Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção .
WO2002086448A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2007030571A3 (en) Identification of targets and development of reagents for testing and molecular imaging of human disease
WO2009062166A3 (en) Dna microarray based identification and mapping of balanced translocation breakpoints
Silveira et al. Comparison between avian pathogenic (APEC) and avian faecal (AFEC) Escherichia coli isolated from different regions in Brazil
WO2007132120A3 (fr) Procede et methodes de detection de la maladie d'alzheimer
AU2010202926B2 (en) Markers and methods relating to the assessment of Alzheimer's disease
BRPI0518405B8 (pt) conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica
EP4273548A3 (en) Serologic assay for silent brain ischemia
NZ592994A (en) Diagnostic test for Streptococcus equi comprising assessing the presence or absence of the S. equi eqbE gene
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2604 DE 01/12/2020 QUANTO AO TITULO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/04/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2717 DE 31-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.